The women’s health rehabilitation products market was estimated to represent a global market of USD 3.59 billion by 2019 with growth rate of 6.1%.
The market is majorly driven by the rising incidence of chronic disease conditions among women population. For example, in 2013, the United States Cancer Statistics (USCS) stated that around 230,815 women were diagnosed with breast cancer. The number was increased to 246,660 in 2016, up 7% compared to the previous year. Similarly, the incidence of neurological disorders, rheumatoid arthritis, and other disabilities are continuously increasing among women population which is expected to fuel the demand for rehabilitation products such as rollators and walkers, tens machines, wheelchairs, etc. For example, according to the Centers for Disease Control and Prevention (CDC), around 52.5 million U.S. people were suffering from arthritis which is projected to reach 78.0 million by 2050.
Furthermore, factors such as rising number of for community-based rehabilitation centers, and technological advancements support the industry growth to some extent. On another side, high cost coupled with low awareness and acceptance of rehab products especially in developing regions pull back the market growth over the forecast period.
Key Vendor Takeaway
Companies such as Access Health, Carib Rehab Ltd., GPC Medical Ltd., Win Health Medical Ltd., and Meyer Physical Therapy are profiled extensively. Among these, Access Health and GPC Medical captured considerable revenue share of the global market. Introduction of novel rehabilitation products and increasing R&D activities geared towards developing products suited to the global market is expected to generate the bulk of industry revenue. For example, in November 2016, Meyer Physical Therapy launched the VENOM, a wearable back device to relax sores, and stiff muscles that aid in rehabilitation and Hypersoothe, the natural cooling creams, to strengthen the HYPERICE brand portfolio.
In terms of products, the market is divided as Urinary Incontinence, Pelvic Pain, Orthopedic Care, Breast Cancer Care, Pregnancy Care, and Other. In 2019, orthopedic care recorded USD 547.9 million and the segment is projected to grow with the 6.3% growth rate over the forecast period. On contrary, rehabilitation devices such as lymphedema and pregnancy-related products are considered to record the lowest revenue in 2019. However, these segments expected to grow with the steady growth rate during the future period.
COVID-19 Impact and Recovery Analysis
The recent outburst of the COVID-19 has led the global women’s health rehabilitation products market to render new offering for combatting with the rising demand for protection against the virus. Due to this outbreak, women’s health rehabilitation products market is projected to gain grip in future.
The published research on women’s health rehabilitation products market provides a bird’s eye view of the current COVID-19 outbreak. Further, the study also considers the post-COVID-19 impact and offers a clear assessment of the projected industry fluctuations. The different factors that are likely to impact the overall market dynamics, including top performer segments, marginal growth segments and top loser segments and more are discussed in detail in this research report.
Regionally, developed regions such as North America and Europe collectively accounted for the highest share (over 65%) of the overall market. Rising cases of chronic disease, coupled with increasing number of target population driver the regional growth. For example, according to the World Health Organization (WHO) report, 64% of the total women population in the United Kingdom are overweight which may increase the risk of problems such as pregnancy related, osteoarthritis, and blood pressure. Such factors would, in turn, spur the utilization of women rehabilitation products in European countries, driving the market growth.
The market size and forecast for each segment has been provided for the period 2016 to 2027, considering 2019 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2021 to 2027 for every reported segment.
The years considered for the study are:
Historical Year – 2016 to 2018
Base Year – 2019
Estimated Year – 2020
Projected Year – 2027
The proposed reports analyse and evaluates the COVID-19 impact, and anticipated change on the future market scenario on this industry, by taking into the account the economic, political, technological, and social, parameters.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
WOMEN’S HEALTH REHABILITATION PRODUCTS MARKET, BY PRODUCT
Breast Cancer Care
WOMEN’S HEALTH REHABILITATION PRODUCTS MARKET, BY THERAPY
WOMEN’S HEALTH REHABILITATION PRODUCTS MARKET, BY REGION
Rest of Europe
Rest of APAC
Rest of the World
Middle East and Africa
Table of Content
- WOMEN’S HEALTH REHABILITATION PRODUCTS MARKET OVERVIEW
- EXECUTIVE SUMMARY
- WOMEN’S HEALTH REHABILITATION PRODUCTS KEY MARKET TRENDS
- WOMEN’S HEALTH REHABILITATION PRODUCTS INDUSTRY STUDY
- WOMEN’S HEALTH REHABILITATION PRODUCTS MARKET LANDSCAPE
- WOMEN’S HEALTH REHABILITATION PRODUCTS MARKET – BY PRODUCT
- WOMEN’S HEALTH REHABILITATION PRODUCTS MARKET – BY THERAPY
- WOMEN’S HEALTH REHABILITATION PRODUCTS MARKET– BY GEOGRAPHY
- KEY VENDOR ANALYSIS
- 360 DEGREE ANALYSTVIEW
Read Other Reports from our Database :
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.
Ph: +162 825 80070 (US)
Ph: +44 203 500 2763 (UK)